B

Biointron Biological Inc.

23 employees

Biointron is committed to providing high-quality and economic recombinant protein/antibody reagents.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
recombinant proteins
Outsourcing
Health Care
cytokines
Stable Cell Line
Antibody Humanization
Antibody Discovery
get purified antibody with 2 weeks from Gene synthesis
100 L fermentor
Service Industry
Medical

Date founded

2012

Funding rounds raised

Total raised

$72M

from 5 investors over 5 rounds

B

Biointron Biological Inc. raised $72M on September 2, 2022

Investors: October Capital, CEBI, Jifeng Ventures 济峰资本, Shenzhen Co-Stone Asset Management and Haitong Securities

FAQ